U.S. Markets open in 30 mins

Novartis AG (NVS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
82.43+0.04 (+0.05%)
At close: 4:00PM EDT

84.49 +2.07 (2.51%)
Before hours: 9:00AM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close82.39
Open83.48
Bid84.22 x 1800
Ask84.45 x 800
Day's Range82.33 - 83.61
52 Week Range69.18 - 99.84
Volume1,640,052
Avg. Volume1,740,523
Market Cap190.507B
Beta (5Y Monthly)0.41
PE Ratio (TTM)26.28
EPS (TTM)3.14
Earnings DateN/A
Forward Dividend & Yield3.09 (3.75%)
Ex-Dividend DateMar 03, 2020
1y Target Est101.00
  • Moody's

    Novartis Securities Investment Ltd -- Moody's announces completion of a periodic review of ratings of Novartis AG

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Novartis AG and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Moody's

    Rossini S.a r.l -- Moody's announces completion of a periodic review of ratings of Rossini S.a r.l

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Rossini S.a r.l and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. Since 1 January 2019, Moody's practice has been to issue a press release following each periodic review to announce its completion.

  • Pharma Stock Roundup: ABBV, MRK Q2 Earnings & Coronavirus Updates in Focus
    Zacks

    Pharma Stock Roundup: ABBV, MRK Q2 Earnings & Coronavirus Updates in Focus

    Sanofi (SNY)/Glaxo (GSK) and J&J (JNJ) sign deals with U.S. government for coronavirus vaccine candidate. Several drugmakers announce second-quarter results.